Mitsuhiro Yoshida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mitsuhiro Yoshida has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Kana Oue
Department of Dental Anesthesiology, Division of Oral and Maxillofacial Surgery and Oral Medicine, Hiroshima University Hospital, Hiroshima, Japan
4 shared publicationsMitsuru Doi
Department of Dental Anesthesiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
4 shared publicationsYoshitaka Shimizu
Department of Dental Anesthesiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
4 shared publicationsAya Oda
Hiroshima University Hospital
3 shared publications- Kana Oue
Department of Dental Anesthesiology, Division of Oral and Maxillofacial Surgery and Oral Medicine, Hiroshima University Hospital, Hiroshima, Japan
3 shared publications Akari Dds Mukai
Department of Dental Anesthesiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Dental Anesthesia and Pain Medicine
- Vol. 26 (4) , 353-358
An anaphylactic reaction without skin manifestations after general anesthesia induction: a case report
Suyama M, et al. J Dent Anesth Pain Med. 2026 Aug;26(4):353-358. https://doi.org/10.17245/jdapm.2026.26.064
- 1 January 2026
- Published by XMLink in Journal of Dental Anesthesia and Pain Medicine
- Vol. 26 (4) , 353-358
Open AccessAn anaphylactic reaction without skin manifestations after general anesthesia induction: a case report
Suyama M, et al. J Dent Anesth Pain Med. 2026 Aug;26(4):353-358. https://doi.org/10.17245/jdapm.2026.26.064
- 1 June 2025
- Published by American Dental Society of Anesthesiology (ADSA) in Anesthesia Progress
- Vol. 72 (2) , 104-108
Anesthetic Management of a Pregnant Patient Undergoing Oral Surgery
Urgent or emergent dental or oral and maxillofacial surgery procedures are acceptable at all stages of pregnancy and encouraged for maintaining the overall wellness of parturients. However, the risks and benefits of nonobstetric surgical procedures under general anesthesia should be weighed carefully because pregnant patients experience significant physiologic remodeling, and many anesthetic drugs and techniques may cause inhibition of fetal development as well as preterm labor and delivery. This case report discusses the choice of anesthetic technique based on the changes in maternal physiology, maintenance of adequate uteroplacental perfusion, avoidance of potentially dangerous drugs during fetal development, and prevention of preterm labor and delivery to ensure maternal safety and maintenance of pregnancy. The case presented highlights the importance of a multidisciplinary approach to ensure adequate anesthetic management in pregnant women.
- 1 June 2025
- Published by American Dental Society of Anesthesiology (ADSA) in Anesthesia Progress
- Vol. 72 (2) , 104-108
Anesthetic Management of a Pregnant Patient Undergoing Oral Surgery
Urgent or emergent dental or oral and maxillofacial surgery procedures are acceptable at all stages of pregnancy and encouraged for maintaining the overall wellness of parturients. However, the risks and benefits of nonobstetric surgical procedures under general anesthesia should be weighed carefully because pregnant patients experience significant physiologic remodeling, and many anesthetic drugs and techniques may cause inhibition of fetal development as well as preterm labor and delivery. This case report discusses the choice of anesthetic technique based on the changes in maternal physiology, maintenance of adequate uteroplacental perfusion, avoidance of potentially dangerous drugs during fetal development, and prevention of preterm labor and delivery to ensure maternal safety and maintenance of pregnancy. The case presented highlights the importance of a multidisciplinary approach to ensure adequate anesthetic management in pregnant women.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Dental Anesthesia and Pain Medicine
- Vol. 25 (3) , 219-221
Articaine as a potential alternative to lidocaine in Japanese dental practice
Yamamoto T, et al. J Dent Anesth Pain Med. 2025 Jun;25(3):219-221. https://doi.org/10.17245/jdapm.2025.25.3.219
- 1 January 2025
- Published by XMLink in Journal of Dental Anesthesia and Pain Medicine
- Vol. 25 (3) , 219-221
Open AccessArticaine as a potential alternative to lidocaine in Japanese dental practice
Yamamoto T, et al. J Dent Anesth Pain Med. 2025 Jun;25(3):219-221. https://doi.org/10.17245/jdapm.2025.25.3.219
- Open Access
- 7 April 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (4) , e8747
Anesthetic management of a patient with Sturge–Weber syndrome in sagittal split ramus osteotomy surgery
Key Clinical Message: Sturge–Weber syndrome (SWS) is a neurocutaneous syndrome characterized by angiomas. This report presents airway management using submental intubation in sagittal split ramus osteotomy under general anesthesia and aimed to explore better anesthetic management for avoiding the rupture of angiomas in a patient with SWS.
- 7 April 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (4) , e8747
Open AccessAnesthetic management of a patient with Sturge–Weber syndrome in sagittal split ramus osteotomy surgery
Key Clinical Message: Sturge–Weber syndrome (SWS) is a neurocutaneous syndrome characterized by angiomas. This report presents airway management using submental intubation in sagittal split ramus osteotomy under general anesthesia and aimed to explore better anesthetic management for avoiding the rupture of angiomas in a patient with SWS.
- Open Access
- 7 April 2024
- Published by Wiley
Anesthetic management of a patient with Sturge--Weber syndrome in sagittal split ramus osteotomy surgery
Key Clinical MessageSturge–Weber syndrome (SWS) is a neurocutaneous syndrome characterized by angiomas. This report presents airway management using submental intubation in sagittal split ramus osteotomy under general anesthesia and aimed to explore better anesthetic management for avoiding the rupture of angiomas in a patient with SWS.
- 7 April 2024
- Published by Wiley
Open AccessAnesthetic management of a patient with Sturge--Weber syndrome in sagittal split ramus osteotomy surgery
Key Clinical MessageSturge–Weber syndrome (SWS) is a neurocutaneous syndrome characterized by angiomas. This report presents airway management using submental intubation in sagittal split ramus osteotomy under general anesthesia and aimed to explore better anesthetic management for avoiding the rupture of angiomas in a patient with SWS.
- 29 May 2023
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 34 (6) , e580-e582
Spinal Muscular Atrophy Type III Recognized After Delayed Recovery From Neuromuscular Blockade After an Orthognathic Surgery
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by the degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle weakness and paralysis. SMA is classified into types I-IV based on the age at symptom onset or maximum motor function achieved, and its clinical manifestations vary. SMA affects maxillofacial growth because of muscle dysfunction and results in abnormal maxillofacial morphology. In addition, definitive diagnosis is not often made because of the older onset age and symptoms are rarely severe. Therefore, the possibility of undiagnosed SMA in craniofacial surgeries must be considered. This report described a case of an SMA type III recognized after delayed recovery from the neuromuscular blockade in an orthognathic surgery under general anesthesia.
- 29 May 2023
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 34 (6) , e580-e582
Spinal Muscular Atrophy Type III Recognized After Delayed Recovery From Neuromuscular Blockade After an Orthognathic Surgery
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by the degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle weakness and paralysis. SMA is classified into types I-IV based on the age at symptom onset or maximum motor function achieved, and its clinical manifestations vary. SMA affects maxillofacial growth because of muscle dysfunction and results in abnormal maxillofacial morphology. In addition, definitive diagnosis is not often made because of the older onset age and symptoms are rarely severe. Therefore, the possibility of undiagnosed SMA in craniofacial surgeries must be considered. This report described a case of an SMA type III recognized after delayed recovery from the neuromuscular blockade in an orthognathic surgery under general anesthesia.
- Open Access
- 11 March 2023
- Published by Elsevier in Neuroscience Letters
- Vol. 802, 137175
N-methyl-d-aspartate receptors and glycinergic transmission, respectively, mediate muscle relaxation and immobility of pentobarbital in mice
- 11 March 2023
- Published by Elsevier in Neuroscience Letters
- Vol. 802, 137175
Open AccessN-methyl-d-aspartate receptors and glycinergic transmission, respectively, mediate muscle relaxation and immobility of pentobarbital in mice
- 14 September 2022
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 34 (1) , e70-e74
Analgesia-based Sedation for Oral Surgery in Patients With Chronic Respiratory Obstructive Disease
Chronic obstructive pulmonary disease (COPD) is a risk factor for postoperative cardiovascular and respiratory complications. Thus, intravenous sedation can be a better option than general anesthesia for surgery in patients with severe COPD. Herein, we present 2 cases of analgesia-based sedation in patients with severe COPD who underwent oral surgery. The current study aimed to discuss these cases to provide knowledge about the appropriate sedation management in patients with this disease. In the current cases, the patients received sufficient analgesia and minimum sedation (analgesia-based sedation). Moreover, dexmedetomidine was used for maintaining sedation and fentanyl for analgesic effects. Furthermore, we focused on providing the maximum analgesic effect of local anesthesia. The patients’ vital signs were stable. They did not have any psychological or physical complaints, such as anxiety and pain, during the procedure. Then, they were discharged from the hospital without any complications. Thus, analgesia-based sedation can be an alternative option for oral surgery in patients with COPD.
- 14 September 2022
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 34 (1) , e70-e74
Analgesia-based Sedation for Oral Surgery in Patients With Chronic Respiratory Obstructive Disease
Chronic obstructive pulmonary disease (COPD) is a risk factor for postoperative cardiovascular and respiratory complications. Thus, intravenous sedation can be a better option than general anesthesia for surgery in patients with severe COPD. Herein, we present 2 cases of analgesia-based sedation in patients with severe COPD who underwent oral surgery. The current study aimed to discuss these cases to provide knowledge about the appropriate sedation management in patients with this disease. In the current cases, the patients received sufficient analgesia and minimum sedation (analgesia-based sedation). Moreover, dexmedetomidine was used for maintaining sedation and fentanyl for analgesic effects. Furthermore, we focused on providing the maximum analgesic effect of local anesthesia. The patients’ vital signs were stable. They did not have any psychological or physical complaints, such as anxiety and pain, during the procedure. Then, they were discharged from the hospital without any complications. Thus, analgesia-based sedation can be an alternative option for oral surgery in patients with COPD.
- 29 October 2020
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 32 (1) , 273-276
Usefulness of Tranexamic Acid Administration During Sagittal Split Ramus Osteotomy
Tranexamic acid has been used to reduce intraoperative bleeding; however, its effect on anti-inflammation and the amount of drainage after orthognathic surgery is yet to be determined. Therefore, we aimed to examine the effect of tranexamic acid on intraoperative bleeding volume and operation time, amount of drainage, and anti-inflammation after orthognathic surgery. Forty healthy women who underwent bilateral sagittal split ramus osteotomy under general anesthesia participated in this study. The amount of intraoperative bleeding, the operation time, the amount of drainage, and the C-reactive protein level were compared between patients intravenously administered with tranexamic acid before surgery (before-surgery group) and those administered with the drug after surgery (after-surgery group). All data were analyzed using the Student t-test. Results were considered to be statistically significant when P < 0.05. Although no significant difference was found in the amount of drainage between the groups (P > 0.05), significant variations were detected in the amount of bleeding during surgery (before-surgery group: 161.7 ± 45.3 mL versus after-surgery group: 270.2 ± 24.0 mL; P = 0.0009), operation time (before-surgery group: 141.3 ± 16.8 min versus after-surgery group: 166.8 ± 24.9 min; P = 0.03), and postoperative C-reactive protein level (before-surgery group: 3.77 ± 0.40 mg/dL versus after-surgery group: 5.02 ± 0.75 mg/dL; P = 0.012) between the groups. In conclusion, administering tranexamic acid before surgery was found to significantly decrease bleeding, reduce operation time, and suppress postoperative inflammation.
- 29 October 2020
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 32 (1) , 273-276
Usefulness of Tranexamic Acid Administration During Sagittal Split Ramus Osteotomy
Tranexamic acid has been used to reduce intraoperative bleeding; however, its effect on anti-inflammation and the amount of drainage after orthognathic surgery is yet to be determined. Therefore, we aimed to examine the effect of tranexamic acid on intraoperative bleeding volume and operation time, amount of drainage, and anti-inflammation after orthognathic surgery. Forty healthy women who underwent bilateral sagittal split ramus osteotomy under general anesthesia participated in this study. The amount of intraoperative bleeding, the operation time, the amount of drainage, and the C-reactive protein level were compared between patients intravenously administered with tranexamic acid before surgery (before-surgery group) and those administered with the drug after surgery (after-surgery group). All data were analyzed using the Student t-test. Results were considered to be statistically significant when P < 0.05. Although no significant difference was found in the amount of drainage between the groups (P > 0.05), significant variations were detected in the amount of bleeding during surgery (before-surgery group: 161.7 ± 45.3 mL versus after-surgery group: 270.2 ± 24.0 mL; P = 0.0009), operation time (before-surgery group: 141.3 ± 16.8 min versus after-surgery group: 166.8 ± 24.9 min; P = 0.03), and postoperative C-reactive protein level (before-surgery group: 3.77 ± 0.40 mg/dL versus after-surgery group: 5.02 ± 0.75 mg/dL; P = 0.012) between the groups. In conclusion, administering tranexamic acid before surgery was found to significantly decrease bleeding, reduce operation time, and suppress postoperative inflammation.